Pages that link to "Q36347256"
Jump to navigation
Jump to search
The following pages link to BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression (Q36347256):
Displaying 50 items.
- Glioma Stem Cells: Signaling, Microenvironment, and Therapy (Q26765854) (← links)
- Development of targeted therapies in treatment of glioblastoma (Q26778787) (← links)
- The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation. (Q27341833) (← links)
- Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells (Q28546959) (← links)
- Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models (Q33894470) (← links)
- Wnt activation promotes neuronal differentiation of glioblastoma (Q33903166) (← links)
- Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). (Q34478948) (← links)
- Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells (Q34645287) (← links)
- The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop (Q35410718) (← links)
- Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma (Q35793678) (← links)
- Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance (Q35828103) (← links)
- Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. (Q36259173) (← links)
- Biological and clinical implications of cancer stem cells in primary brain tumors (Q36562573) (← links)
- Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitylation by USP22. (Q37262177) (← links)
- Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance (Q37441234) (← links)
- BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells. (Q37487279) (← links)
- Targeting cancer stem cells to suppress acquired chemotherapy resistance (Q38149736) (← links)
- BMPs as therapeutic targets and biomarkers in astrocytic glioma (Q38216033) (← links)
- MGMT testing--the challenges for biomarker-based glioma treatment (Q38218848) (← links)
- Taking advantage of neural development to treat glioblastoma (Q38223161) (← links)
- Stem cells and gliomas: past, present, and future. (Q38235856) (← links)
- Cancer stem cells: are they responsible for treatment failure? (Q38268164) (← links)
- Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma. (Q38431462) (← links)
- Transforming growth factor β and bone morphogenetic protein actions in brain tumors (Q38469127) (← links)
- Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles (Q38566898) (← links)
- Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment (Q38777339) (← links)
- Annexin 2A sustains glioblastoma cell dissemination and proliferation (Q38840667) (← links)
- TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry (Q38854837) (← links)
- Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model (Q38894617) (← links)
- Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer (Q39008172) (← links)
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy (Q39017301) (← links)
- Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner. (Q39156092) (← links)
- Bortezomib downregulates MGMT expression in T98G glioblastoma cells (Q39207783) (← links)
- Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma (Q39354541) (← links)
- HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy (Q40231870) (← links)
- HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels (Q41367064) (← links)
- Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells (Q43193981) (← links)
- The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients (Q43778254) (← links)
- Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected]. (Q44737792) (← links)
- The Dual Role of Bone Morphogenetic Proteins in Cancer (Q47163689) (← links)
- A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells. (Q51746123) (← links)
- Distinct response to GDF15 knockdown in pediatric and adult glioblastoma cell lines. (Q52316138) (← links)
- microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. (Q53059683) (← links)
- CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells. (Q55010335) (← links)
- PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma. (Q55139727) (← links)
- Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells. (Q55287129) (← links)
- BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma (Q57177045) (← links)
- Blockade of Na/H exchanger stimulates glioma tumor immunogenicity and enhances combinatorial TMZ and anti-PD-1 therapy (Q59129078) (← links)
- Sequential treatment of phenethyl isothiocyanate increases sensitivity of Temozolomide resistant glioblastoma cells by decreasing expression of MGMT via NF-κB pathway (Q64261069) (← links)
- MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression (Q87676566) (← links)